- 1) Nichols MT, Russ PD, and Chen YK, Pancreas, 33, 211–220 (2006).
- 2) Guha S, Lunn JA, Santiskulvong C, and Rozengurt E, Cancer Res., 63, 2379–2387 (2003).
- 3) Kleeff J, Michalski C, Friess H, and Buchler MW, Pancreas, 33, 111–118 (2006).
- 4) Yeh JJ and Der CJ, Expert Opin. Ther. Targets, 11, 673–694 (2007).
- 5) Von Hoff DD, Best Pract. Res. Clin. Gastroentrol., 20, 315–326 (2006).
- 6) Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, and Esumi H, Cancer Res., 66, 1751–1757 (2006).
- 7) Kokkinakis DM, Liu XY, and Neuner RD, Mol. Cancer Ther., 4, 1338–1348 (2005).
- 8) Izuishi K, Kato K, Ogura T, Kinoshita T, and Esumi H, Cancer Res., 60, 6201–6207 (2000).
- 9) Ogiso Y, Tomida A, Kim HD, and Tsuruo T, Biochem. Biophys. Res. Commun., 258, 448–452 (1999).
- 10) Ogiso Y, Tomida A, Lei S, Omura S, and Tsuruo T, Cancer Res., 60, 2429–2434 (2000).
- 11) Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, Hayakawa Y, Tsuruo T, and Shin-ya K, J. Natl. Cancer Inst., 96, 1300–1310 (2004).
- 12) Luo S, Baumeister P, Yang S, Abcouwer SF, and Lee AS, J. Biol. Chem., 278, 37375–37385 (2003).
- 13) Feldman DE, Chauhan V, and Koong AC, Mol. Cancer Res., 3, 597–605 (2005).
- 14) Park HR, Ryoo IJ, Choo SJ, Hwang JH, Kim JY, Cha MR, Shin-ya K, and Yoo ID, Toxicology, 229, 253–261 (2007).
- 15) Li J and Lee AS, Curr. Mol. Med., 6, 45–54 (2006).
- 16) Hets C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antocsson B, Brandt GS, Iwakoshi NN, Schinzel A, Glimcher LH, and Korsmeyer SJ, Science, 312, 572–576 (2006).
- 17) Zhang K and Kaufman RJ, J. Biol. Chem., 279, 25935–25938 (2004).
- 18) Kadowaki H, Nishitoh H, and Ichijo H, J. Chem. Neuroanat., 28, 93–100 (2004).
- 19) Tomida A and Tsuruo T, Anticancer Drug Des., 14, 169–177 (1999).
- 20) Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, and Haga N, Cancer Sci., 94, 15–21 (2003).
- 21) Fu Y and Lee AS, Cancer Biol. Ther., 5, 741–744 (2006).
- 22) Lee AS, Trends Biochem. Sci., 26, 504–510 (2001).
- 23) Sausville EA, J. Natl. Cancer Inst., 96, 1266–1267 (2004).
Full access
Selective Cytotoxicity of Ponciri Fructus against Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells via Blocking Activation of GRP78
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.